Author: admin

  • Get ready for a spectacular IPO boom from the big beasts of Silicon Valley

    Get ready for a spectacular IPO boom from the big beasts of Silicon Valley

    Unlock the Editor’s Digest for free

    It normally takes a lot more than three companies to create an initial public offering boom. But if those three companies are SpaceX, OpenAI and Anthropic, Wall Street may soon find itself in the middle of an IPO boom for the ages.

    In one of the first clear signs that some of the most valuable private tech companies have set the wheels in motion to go public, the Financial Times last week reported Anthropic had appointed lawyers to lay the groundwork. That puts it a step ahead of OpenAI, which is also considering an IPO. Reports in recent days, first by Bloomberg, suggest Elon Musk’s rocket company SpaceX is also gearing up to go public.

    It’s not hard to see why. Private equity investors have provided huge amounts of capital for these companies, but they have their limits. OpenAI has raised $41bn of equity this year and will need much more before turning a profit. SpaceX is reported to be planning to raise more than $30bn in an IPO.

    They would fill a useful niche for public market investors. As pure-play model builders, OpenAI and Anthropic would provide a new way for Wall Street to bet on artificial intelligence. And SpaceX, which accounted for more than half of all rocket launches last year, would be unrivalled as a wager on the future space economy.

    If all three go public at roughly the same time, possibly next year, it would be an extraordinary moment for Wall Street. The headline numbers would be head-spinning. SpaceX is hoping to be valued at $800bn in its latest private share sale, while Anthropic is targeting $350bn. OpenAI’s most recent share sale was at $500bn.

    Given that anyone investing now would be hoping for another big lift before IPO day, the eventual numbers, if all goes to plan, would be much larger still. Any one of these would put the previous record for a tech IPO — the valuation of more than $230bn Alibaba achieved in its 2014 debut — in the shade.

    They might also break new ground with the scale of their losses and need to convince investors of the sustainability of their business models. 

    One indicator of the amount of red ink OpenAI is spilling has come from Microsoft, which put its share of the AI company’s losses at $4.1bn in the latest quarter. Given that it owned about a third of the company, that suggests the ChatGPT maker as a whole may have lost roughly $12bn — a daunting figure, though one-off factors or other things may have inflated the number.

    At the same time, though, the growth of OpenAI’s business since the launch of ChatGPT has been nothing short of spectacular, and another year or 18 months could make a huge difference.

    Its revenue has grown in rough proportion to its data-centre capacity, roughly tripling in each of the past two years, said a person familiar with its finances. With just under 2 gigawatts of capacity, it is ending this year with revenue at an annualised rate of $20bn. The company’s plans call for capacity to jump to 6GW — 6.5GW by the end of next year. It seems cautiously optimistic that the pattern will hold, putting the revenue run-rate at $60bn by the end of 2026, though a number of questions around the timing of its ability to monetise its new data centres may complicate the picture. 

    Even when they are willing to back lossmakers, though, public markets have a way of turning up the heat. Uber, the last big lossmaking tech company to list, faced intense pressure in its early years. It was not until after it reported its first operating profit years later that its shares finally found a sustainable level above the IPO price.

    Then there is the question of governance. Wall Street has been open to tech companies that concentrate voting power in the hands of founders. It has less experience of groups whose missions might put them at odds with the interests of their shareholders.

    A fundamental question hangs over the crop of mega-IPO candidates. Does OpenAI see ChatGPT and others as a way to fund its original mission, which was to make sure AI benefits all of humanity? Or is it a profit-maximising business that just happens to see helping humanity as a side-benefit?

    A similar question hangs over SpaceX. If Musk’s overriding goal is to get to Mars — the reason he said he set the company up — what kind of trade-offs might his company make between profitability and space exploration?

    The stock market, though, has shown plenty of appetite for one Musk stock, lifting Tesla well above its possible value as a pure car company. Given the chance to invest in the dominant commercial rocket company, there is every reason to believe it would welcome a second.

    richard.waters@ft.com

    Continue Reading

  • S&P 500 Hovers Near Record as Dip Buyers Step Up: Markets Wrap

    S&P 500 Hovers Near Record as Dip Buyers Step Up: Markets Wrap

    (Bloomberg) — Buyers emerged for US stocks after concerns on Oracle Corp.’s plans for vast capital outlays on artificial-intelligence infrastructure drove a broad retreat from risky assets.

    The S&P 500 clawed back losses to climb 0.1%, putting it back near its October peak. Blue-chip and small-cap gauges, long laggards in the tech-led equity bull run, climbed to all-time highs. The Nasdaq 100 pared a 1.6% drop, though sentiment for tech stocks remained downbeat after a disappointing earnings report for Oracle, a bellwether of the AI investment boom. Traders will get another read on the strength of the AI trade when Broadcom Inc. reports after the close.

    Subscribe to the Stock Movers Podcast on Apple, Spotify and other Podcast Platforms.

    Caution toward AI heavyweights persisted, with Nvidia Corp. down around 1.9% amid Magnificent Seven losses. Bitcoin pared a drop after dipping below $90,000. The dollar ticked lower.

    Broadcom’s stock has more than doubled from its April low, and Bloomberg Intelligence expects results that are in line with, or slightly above, estimates as hyperscaler customers continue to ramp up spending.

    Oracle’s results pushed worries about tech valuations and whether heavy spending on AI infrastructure will pay off back into focus, reviving concerns that fueled weeks of volatility in November. While the sector has powered the S&P 500’s stunning rally this year, spending fears have prompted some investors to rotate into other areas as the US economic outlook remains robust.

    “Markets have grown far more wary of AI-related spending, which is a sharp contrast with mid-2025 when anything hinting at higher capex sparked excitement,” said Susana Cruz, a strategist at Panmure Liberum. “Oracle has been the weakest link in all this, largely because it’s funding a big chunk of its investment with debt.”

    Oracle’s earnings landed after the S&P 500 closed just shy of a record on Wednesday, lifted by a Federal Reserve interest-rate cut and Chair Jerome Powell’s sanguine economic outlook.

    Investors had taken comfort in Fed policymakers leaving the door open to more easing next year, even though the quarter-point cut drew three dissents. Traders stuck to bets on two cuts in 2026, even as the Fed’s new projections signaled only one such move.

    “The effect of Oracle has been greater than the Fed. This already tells us everything as we’ve been witnessing a strong concentration and one theme — AI — leading the market,” said Alberto Tocchio, a portfolio manager at Kairos Partners. “This doesn’t mean that AI is gone or it’s a bubble, but we need to focus on a wider scale.”

    US Treasuries rallied after the rate cut was paired with the authorization of fresh bill purchases to rebuild bank reserves. The gains continued after initial jobless claims rose more than expected in the Dec. 6 week, but waned in late afternoon trading as the yield on the 10-year note steadied at 4.14%.

    Powell suggested that the Fed had now acted sufficiently to help stabilize the labor market while leaving rates high enough to continue weighing on price pressures. Officials upgraded their median outlook for growth in 2026, to 2.3% from the 1.8% they projected in September. They also foresaw inflation declining to 2.4% next year, from the 2.6% in the previous projection.

    “The Fed’s ‘hawkish-but-bullish’ cut last night reinforces this: stronger 2026 growth, faster disinflation,” said Florian Ielpo, head of macro at Lombard Odier Investment Managers. “Cuts are continuing, but they’re no longer automatic — and that’s usually a constructive backdrop for equities.”

    In commodities, oil retreated tracking wider losses in risk assets. Silver extended an all-time high past $63 an ounce.

    What Bloomberg Strategists say…

    “Rather than signaling an imminent bust in tech shares, Oracle’s earnings disappointment is poised to further redefine the divide between AI winners and losers. The next stage of the AI cycle promises even more dispersion, as companies battle for a share of booming AI spending as well as superior efficiency and cost advantages on the provider side.”

    —Tatiana Darie, Macro Strategist, Markets Live. For the full analysis, click here.

    Corporate News

    Walt Disney Co. agreed to invest $1 billion in OpenAI and license characters from Disney, Marvel, Pixar and Star Wars for use on the Sora generative video platform. A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. The stock rose in premarket trading. Oracle Corp. shares fell in early trading after the company reported a jump in spending on AI data centers and other equipment, rising outlays that are taking longer to translate into cloud revenue than investors want. OpenAI and its investor Microsoft were sued over a Connecticut murder-suicide in the latest case to blame the popular ChatGPT chatbot for dangerous psychological manipulation of users. Novo Nordisk A/S shares have fallen so much this year that it’s almost as if the frenzy around weight-loss drugs that propelled the Danish pharmaceutical company’s meteoric rise never happened. Coca-Cola Co. said Chief Executive Officer James Quincey is stepping down and will be replaced at the end of March by Henrique Braun, the company’s chief operating officer. Some of the main moves in markets:

    Stocks

    The S&P 500 rose 0.1% as of 3:32 p.m. New York time The Nasdaq 100 fell 0.5% The Dow Jones Industrial Average rose 1.4% The MSCI World Index rose 0.3% The Russell 2000 Index rose 1.2% Currencies

    The Bloomberg Dollar Spot Index fell 0.3% The euro rose 0.4% to $1.1743 The British pound was little changed at $1.3392 The Japanese yen rose 0.3% to 155.54 per dollar Cryptocurrencies

    Bitcoin fell 1.3% to $91,177.64 Ether fell 4% to $3,206.95 Bonds

    The yield on 10-year Treasuries was little changed at 4.14% Germany’s 10-year yield was little changed at 2.84% Britain’s 10-year yield declined two basis points to 4.48% Commodities

    West Texas Intermediate crude fell 1.2% to $57.75 a barrel Spot gold rose 1% to $4,270.69 an ounce This story was produced with the assistance of Bloomberg Automation.

    –With assistance from Neil Campling and Sagarika Jaisinghani.

    ©2025 Bloomberg L.P.

    Continue Reading

  • McLaren Racing celebrates the 2025 F1 Drivers’ Championship success at the MTC

    McLaren Racing celebrates the 2025 F1 Drivers’ Championship success at the MTC

    Lando Norris, Driver, McLaren Formula 1 Team, said: 

    “It’s unbelievable to be here as a Drivers’ World Champion. It’s been my dream since all those years ago, watching on TV and wondering what it’s like to be there one day, with no…

    Continue Reading

  • The United States CDC has abandoned science in its new advice about vaccines and autism

    The United States CDC has abandoned science in its new advice about vaccines and autism

    The United States Centers for Disease Control and Prevention (CDC) has revised its long-standing guidance about vaccines and autism.

    The guidance once stated clearly and correctly that the evidence shows no link between vaccines and the…

    Continue Reading

  • Midlife influenza vaccine not associated with increased risk of Parkinson’s disease, study shows

    Midlife influenza vaccine not associated with increased risk of Parkinson’s disease, study shows

    Receiving an influenza vaccine between the ages of 40 and 50 does not increase the risk of Parkinson’s disease, according to the results of a recent study published in JAMA Network Open.

    While there was no increased risk of Parkinson’s…

    Continue Reading

  • Teenagers with body image issues may develop eating disorders and depression later

    Teenagers with body image issues may develop eating disorders and depression later

    Teenagers who are unhappy with their bodies are more likely to develop symptoms of eating disorders and depression in early adulthood, according to a new study led by UCL researchers.

    The research, believed to be the first of its…

    Continue Reading

  • The Athletic: Llama drama: Keldon Johnson, Spurs are taking the NBA Cup very seriously

    The Athletic: Llama drama: Keldon Johnson, Spurs are taking the NBA Cup very seriously

    Editor’s Note: Read more NBA coverage from The Athletic here. The views on this page do not necessarily reflect the views of the NBA or its teams. 

    ***

    LOS ANGELES — All Keldon Johnson wanted was his llama.

    The NBA Cup comes with a…

    Continue Reading

  • Rayan gains redemption as Faiqa claims fourth gold at National Games – Dawn

    1. Rayan gains redemption as Faiqa claims fourth gold at National Games  Dawn
    2. Rayan gains redemption as Faiqa claims fourth gold  Dawn
    3. Pakistan Army storms past 100-gold mark to dominate 35th National Games  The Express Tribune
    4. Army rule the rankings,…

    Continue Reading

  • Songbirds swap colorful plumage genes across species lines among their evolutionary neighbors

    Songbirds swap colorful plumage genes across species lines among their evolutionary neighbors

    People typically think about evolution as a linear process where, within a species, the classic adage of “survival of the fittest” is constantly at play. New DNA mutations arise and get passed from parents to offspring. If any genetic…

    Continue Reading

  • Come See Me in the Good Light Director Interview: Andrea Gibson Legacy

    Come See Me in the Good Light Director Interview: Andrea Gibson Legacy

    Ryan White wasn’t completely sure what would come of his first meeting with poet-activist Andrea Gibson and their wife, Megan Falley, when he was approached with the idea of making a film about the artist’s pending death. “I had never…

    Continue Reading